Correspondence 0001193125-23-258648 from Abivax S.A. (ABVX) (CIK 0001956827) (ABVX)
Abivax S.A. (ABVX) (CIK 0001956827)
Date: Oct. 18, 2023 · CIK: 0001956827 · Accession: 0001193125-23-258648
AI Filing Summary & Sentiment
File numbers found in text: 333-274780
Letter
Underwriter Acceleration Request
October 18, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Joshua Gorsky
Jason Drory
Vanessa Robertson
Mary Mast
Re:
Abivax SA
Registration Statement on Form F-1
File No. 333-274780
Acceleration Request
Requested Date: October 19, 2023
Requested Time: 4:00 P.M. Eastern Time
To the addressees set forth above:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Abivax SA (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement, requesting effectiveness as of 4:00 P.M., Eastern Time, on October 19, 2023, or at such later time as the Company or its outside counsel, Cooley LLP, may request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature Page Follows]
Sincerely,
MORGAN STANLEY & CO. LLC
Show Raw Text
CORRESP 1 filename1.htm Underwriter Acceleration Request October 18, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Jason Drory Vanessa Robertson Mary Mast Re: Abivax SA Registration Statement on Form F-1 File No. 333-274780 Acceleration Request Requested Date: October 19, 2023 Requested Time: 4:00 P.M. Eastern Time To the addressees set forth above: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Abivax SA (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement, requesting effectiveness as of 4:00 P.M., Eastern Time, on October 19, 2023, or at such later time as the Company or its outside counsel, Cooley LLP, may request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement. We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Signature Page Follows] Sincerely, MORGAN STANLEY & CO. LLC LEERINK PARTNERS LLC As representatives of the several underwriters MORGAN STANLEY & CO. LLC By: /s/ Chirag D. Surti Name: Chirag D. Surti Title: Executive Director LEERINK PARTNERS LLC By: /s/ Jack Bannister Name: Jack Bannister Title: Senior Managing Director [Signature Page to Underwriters’ Acceleration Request]